329 related articles for article (PubMed ID: 23938262)
1. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.
Khoo SK; Petillo D; Kang UJ; Resau JH; Berryhill B; Linder J; Forsgren L; Neuman LA; Tan AC
J Parkinsons Dis; 2012; 2(4):321-31. PubMed ID: 23938262
[TBL] [Abstract][Full Text] [Related]
2. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.
Botta-Orfila T; Morató X; Compta Y; Lozano JJ; Falgàs N; Valldeoriola F; Pont-Sunyer C; Vilas D; Mengual L; Fernández M; Molinuevo JL; Antonell A; Martí MJ; Fernández-Santiago R; Ezquerra M
J Neurosci Res; 2014 Aug; 92(8):1071-7. PubMed ID: 24648008
[TBL] [Abstract][Full Text] [Related]
3. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.
Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY
Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A
Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.
Chen Q; Deng N; Lu K; Liao Q; Long X; Gou D; Bi F; Zhou J
Sci Rep; 2021 Jul; 11(1):15268. PubMed ID: 34315950
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis.
Wang WT; Zhao YN; Han BW; Hong SJ; Chen YQ
J Clin Endocrinol Metab; 2013 Jan; 98(1):281-9. PubMed ID: 23118427
[TBL] [Abstract][Full Text] [Related]
7. Combinatory microRNA serum signatures as classifiers of Parkinson's disease.
Patil KS; Basak I; Dalen I; Hoedt E; Lange J; Lunde KA; Liu Y; Tysnes OB; Forsgren L; Aarsland D; Neubert TA; Larsen JP; Alves G; Møller SG
Parkinsonism Relat Disord; 2019 Jul; 64():202-210. PubMed ID: 31003905
[TBL] [Abstract][Full Text] [Related]
8. Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease.
Ding H; Huang Z; Chen M; Wang C; Chen X; Chen J; Zhang J
Parkinsonism Relat Disord; 2016 Jan; 22():68-73. PubMed ID: 26631952
[TBL] [Abstract][Full Text] [Related]
9. Identification of blood microRNAs associated to Parkinsonĭs disease.
Margis R; Margis R; Rieder CR
J Biotechnol; 2011 Mar; 152(3):96-101. PubMed ID: 21295623
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.
Teixeira Dos Santos MC; Bell R; da Costa AN
Bioanalysis; 2016 Dec; 8(23):2497-2518. PubMed ID: 27855513
[TBL] [Abstract][Full Text] [Related]
12. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.
Schwienbacher C; Foco L; Picard A; Corradi E; Serafin A; Panzer J; Zanigni S; Blankenburg H; Facheris MF; Giannini G; Falla M; Cortelli P; Pramstaller PP; Hicks AA
J Mol Neurosci; 2017 Jun; 62(2):244-254. PubMed ID: 28540642
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
Cao XY; Lu JM; Zhao ZQ; Li MC; Lu T; An XS; Xue LJ
Neurosci Lett; 2017 Mar; 644():94-99. PubMed ID: 28223160
[TBL] [Abstract][Full Text] [Related]
14. Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples.
Chen L; Yang J; Lü J; Cao S; Zhao Q; Yu Z
Brain Behav; 2018 Apr; 8(4):e00941. PubMed ID: 29670823
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.
Yadav SK; Jauhari A; Singh N; Pandey A; Sarkar S; Pandey S; Garg RK; Parmar D; Yadav S
Cell Mol Neurobiol; 2023 Oct; 43(7):3527-3553. PubMed ID: 37219663
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-221 serves as a biomarker for Parkinson's disease.
Ma W; Li Y; Wang C; Xu F; Wang M; Liu Y
Cell Biochem Funct; 2016 Oct; 34(7):511-515. PubMed ID: 27748571
[TBL] [Abstract][Full Text] [Related]
17. Found in transcription: accurate Parkinson's disease classification in peripheral blood.
Karlsson MK; Sharma P; Aasly J; Toft M; Skogar O; Sæbø S; Lönneborg A
J Parkinsons Dis; 2013; 3(1):19-29. PubMed ID: 23938308
[TBL] [Abstract][Full Text] [Related]
18. Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients.
Ravanidis S; Bougea A; Papagiannakis N; Koros C; Simitsi AM; Pachi I; Breza M; Stefanis L; Doxakis E
Ann Clin Transl Neurol; 2020 Sep; 7(9):1594-1607. PubMed ID: 32860338
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.
Li N; Pan X; Zhang J; Ma A; Yang S; Ma J; Xie A
Neurol Sci; 2017 May; 38(5):761-767. PubMed ID: 28181066
[TBL] [Abstract][Full Text] [Related]
20. Hypothesis: Do miRNAs Targeting the Leucine-Rich Repeat Kinase 2 Gene (LRRK2) Influence Parkinson's Disease Susceptibility?
Yılmaz ŞG; Geyik S; Neyal AM; Soko ND; Bozkurt H; Dandara C
OMICS; 2016 Apr; 20(4):224-8. PubMed ID: 27093107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]